Focal Seizure clinical trials

Explore recruiting focal seizure clinical trials.

Recruiting focal seizure studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Focal Seizure trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Double-Blind, Randomized, Multicenter, Trial Evaluating the Efficacy and Safety of PRAX-628 in Adults with Focal Seizures (POWER 1)

Spain, Poland, Italy

Phase II and Phase III (Integrated) EU CTIS Study details

A Randomized, Double-blind, Placebo-Controlled, Multicenter Phase 3 Study to Evaluate the Safety, Tolerability, and Efficacy of XEN1101 as Adjunctive Therapy in Focal-Onset Seizures

Spain, Poland, Bulgaria, Italy, Germany, Ireland +3 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Randomized, Double-blind, Placebo-Controlled, Multicenter Phase 3 Study to Evaluate the Safety, Tolerability, and Efficacy of XEN1101 as Adjunctive Therapy in Focal-Onset Seizures

Bulgaria, Italy, Spain, Croatia, Portugal, Czechia +8 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Randomized, Double-blind, Placebo-Controlled, Multicenter Study to Evaluate the Safety, Tolerability, and Efficacy of XEN1101 as Adjunctive Therapy in Focal-Onset Epilepsy, With an Open-label Extension

Spain, Germany, Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

A Double-blind, Randomized Clinical Trial Evaluating the Efficacy and Safety of Vormatrigine in Adults with Focal Seizures

Poland, Germany, Czechia, Italy, Spain

Therapeutic confirmatory (Phase III) EU CTIS Study details

The ENACT Trial: A Randomized, double-blind, placebo-controlled adjunctive treatment trial to evaluate the efficacy and safety of ENX-101 in patients with focal (partial onset) seizures

Germany, Belgium, Netherlands, Spain

Therapeutic exploratory (Phase II) EU CTIS Study details

Focal Seizure trials by city

Focal Seizure in Toronto Focal Seizure in Vancouver Focal Seizure in Montreal Focal Seizure in Calgary Focal Seizure in Edmonton Focal Seizure in Ottawa Focal Seizure in Winnipeg Focal Seizure in Quebec City Focal Seizure in Hamilton Focal Seizure in Kitchener Focal Seizure in London Focal Seizure in Halifax Focal Seizure in New York Focal Seizure in Los Angeles Focal Seizure in Chicago Focal Seizure in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease